Graham P. Allaway

68 year

Health Technology

Consumer Services

Commercial Services

Profile

Graham P.
Allaway was Chief Operating Officer of Panacos Pharmaceuticals, Inc. from May 3, 2005 to February 27, 2009.
Dr. Allaway was Senior Vice President for Drug Discovery at Boston Biomedica Inc., which he joined in 1998.
Prior to this, he was Chief Executive Officer of Manchester Biotech from 1997 to 1998.
Dr. Allaway received his MA in Zoology from the University of Oxford and his PhD in Virology from the University of London.

Former positions of Graham P. Allaway

Companies	Position	End
PANACOS PHARMACEUTICALS, INC.	Founder	27/02/2009
Panacos Pharmaceuticals, Inc. /Old/ Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection	President	03/03/2005
Manchester Biotech Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company.	President	01/01/1998
PRESSURE BIOSCIENCES, INC.	Corporate Officer/Principal	-

See the detail of Graham P. Allaway's experience

Training of Graham P. Allaway

University of Oxford	Graduate Degree
University of London	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Graham P. Allaway's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
PRESSURE BIOSCIENCES, INC.	Health Technology
PANACOS PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Manchester Biotech Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company.	Health Technology
Panacos Pharmaceuticals, Inc. /Old/ Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection	Commercial Services